AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionWP Advisors, LLC
Latest Disclosed Ownership34,313 shares
Latest Disclosed Value $ 7,462,832
WP Advisors, LLC reports 0.33% decrease in ownership of 4AB / AbbVie Inc.

On May 4, 2026 - WP Advisors, LLC filed a 13F-HR form disclosing ownership of 34,313 shares of AbbVie Inc. (BG:4AB) valued at $7,462,832 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 34,425 shares of AbbVie Inc.. This represents a change in shares of -0.33% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F ABBVIE COM 00287Y109 34,313 -112 -0.33 7,463 -5.12 1.9306
2026-01-28 2025-12-31 13F ABBVIE COM 00287Y109 34,425 -99 -0.29 7,866 -1.60 1.9590
2025-10-22 2025-09-30 13F ABBVIE COM 00287Y109 34,524 177 0.52 7,994 25.38 2.0320
2025-08-08 2025-06-30 13F ABBVIE COM 00287Y109 34,347 487 1.44 6,376 -10.14 1.7510
2025-05-12 2025-03-31 13F ABBVIE COM 00287Y109 33,860 96 0.28 7,094 18.25 2.3620
2025-02-03 2024-12-31 13F ABBVIE COM 00287Y109 33,764 349 1.04 6,000 -9.08 1.9989
2024-11-07 2024-09-30 13F ABBVIE COM 00287Y109 33,415 -2,066 -5.82 6,599 8.43 2.4112
2024-07-30 2024-06-30 13F ABBVIE COM 00287Y109 35,481 -113 -0.32 6,086 -6.11 1.9433
2024-05-08 2024-03-31 13F ABBVIE COM 00287Y109 35,594 -145 -0.41 6,482 17.03 2.1263
2024-01-31 2023-12-31 13F ABBVIE COM 00287Y109 35,739 -243 -0.68 5,539 3.26 2.0503
2023-10-30 2023-09-30 13F ABBVIE COM 00287Y109 35,982 295 0.83 5,363 11.54 2.2176
2023-07-26 2023-06-30 13F ABBVIE COM 00287Y109 35,687 -775 -2.13 4,808 -17.25 1.9238
2023-04-14 2023-03-31 13F ABBVIE COM 00287Y109 36,462 153 0.42 5,811 -0.97 2.3969
2023-01-20 2022-12-31 13F ABBVIE COM 00287Y109 36,309 -335 -0.91 5,868 19.30 2.6233
2022-10-24 2022-09-30 13F Abbvie COM 00287Y109 36,644 444 1.23 4,918 -11.29 2.2269
2022-07-12 2022-06-30 13F Abbvie COM 00287Y109 36,200 81 0.22 5,544 -5.31 2.4100
2022-04-25 2022-03-31 13F Abbvie COM 00287Y109 36,119 -1,400 -3.73 5,855 15.26 2.4113
2022-02-02 2021-12-31 13F Abbvie COM 00287Y109 37,519 -221 -0.59 5,080 24.79 2.1164
2021-10-20 2021-09-30 13F Abbvie COM 00287Y109 37,740 -437 -1.14 4,071 -5.33 1.6694
2021-07-22 2021-06-30 13F Abbvie COM 00287Y109 38,177 -294 -0.76 4,300 3.29 1.7927
2021-05-06 2021-03-31 13F Abbvie COM 00287Y109 38,471 1,394 3.76 4,163 4.78 1.7985
2021-01-27 2020-12-31 13F Abbvie COM 00287Y109 37,077 308 0.84 3,973 23.35 1.9186
2020-10-16 2020-09-30 13F Abbvie COM 00287Y109 36,769 7,103 23.94 3,221 10.57 1.9411
2020-08-07 2020-06-30 13F Abbvie COM 00287Y109 29,666 1,303 4.59 2,913 34.80 2.0483
2020-04-29 2020-03-31 13F Abbvie COM 00287Y109 28,363 -220 -0.77 2,161 -14.62 2.0991
2020-01-22 2019-12-31 13F Abbvie COM 00287Y109 28,583 -1,162 -3.91 2,531 12.39 2.6128
2019-10-22 2019-09-30 13F Abbvie COM 00287Y109 29,745 -4,490 -13.12 2,252 -9.56 2.5812
2019-07-23 2019-06-30 13F Abbvie COM 00287Y109 34,235 1,981 6.14 2,490 -90.42 2.7763
2019-04-15 2019-03-31 13F Abbvie COM 00287Y109 32,254 92 0.29 25,994 776.69 2.8298
2019-01-17 2018-12-31 13F Abbvie COM 00287Y109 32,162 -313 -0.96 2,965 -3.45 2.9231
2018-10-31 2018-09-30 13F Abbvie COM 00287Y109 32,475 -424 -1.29 3,071 0.75 2.8587
2018-07-26 2018-06-30 13F Abbvie COM 00287Y109 32,899 192 0.59 3,048 -1.55 2.8759
2018-05-04 2018-03-31 13F Abbvie COM 00287Y109 32,707 -5,400 -14.17 3,096 -15.98 3.3428
2018-02-05 2017-12-31 13F Abbvie COM 00287Y109 38,107 -2,647 -6.50 3,685 1.77 3.5675
2017-11-02 2017-09-30 13F Abbvie COM 00287Y109 40,754 -427 -1.04 3,621 21.27 2.7349
2017-08-08 2017-06-30 13F Abbvie COM 00287Y109 41,181 -2,047 -4.74 2,986 6.00 2.1640
2017-04-17 2017-03-31 13F Abbvie COM 00287Y109 43,228 2,130 5.18 2,817 9.44 1.7691
2017-02-10 2016-12-31 13F Abbvie COM 00287Y109 41,098 41,098 2,574 1.7970
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.